A detailed history of Swiss National Bank transactions in Insmed Inc stock. As of the latest transaction made, Swiss National Bank holds 302,500 shares of INSM stock, worth $21.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
302,500
Previous 277,500 9.01%
Holding current value
$21.6 Million
Previous $18.6 Million 18.77%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$62.0 - $79.01 $1.55 Million - $1.98 Million
25,000 Added 9.01%
302,500 $22.1 Million
Q2 2024

Aug 08, 2024

BUY
$22.0 - $69.71 $200,200 - $634,361
9,100 Added 3.39%
277,500 $18.6 Million
Q1 2024

May 07, 2024

SELL
$25.72 - $29.94 $20,576 - $23,952
-800 Reduced 0.3%
268,400 $7.28 Million
Q4 2023

Feb 06, 2024

SELL
$23.42 - $31.74 $718,994 - $974,418
-30,700 Reduced 10.24%
269,200 $8.34 Million
Q3 2023

Nov 08, 2023

BUY
$19.86 - $26.93 $57,594 - $78,097
2,900 Added 0.98%
299,900 $7.57 Million
Q2 2023

Aug 09, 2023

BUY
$16.44 - $21.1 $75,624 - $97,060
4,600 Added 1.57%
297,000 $6.27 Million
Q1 2023

May 10, 2023

SELL
$16.26 - $21.73 $495,930 - $662,765
-30,500 Reduced 9.45%
292,400 $4.99 Million
Q4 2022

Feb 08, 2023

BUY
$16.98 - $23.15 $670,710 - $914,425
39,500 Added 13.94%
322,900 $6.45 Million
Q3 2022

Nov 09, 2022

BUY
$20.88 - $28.21 $73,080 - $98,735
3,500 Added 1.25%
283,400 $6.1 Million
Q1 2022

May 09, 2022

BUY
$20.42 - $28.13 $557,466 - $767,949
27,300 Added 10.81%
279,900 $6.58 Million
Q4 2021

Feb 08, 2022

BUY
$25.89 - $33.45 $46,602 - $60,210
1,800 Added 0.72%
252,600 $6.88 Million
Q3 2021

Nov 08, 2021

BUY
$22.46 - $29.47 $532,302 - $698,439
23,700 Added 10.44%
250,800 $6.91 Million
Q2 2021

Aug 06, 2021

SELL
$24.17 - $36.01 $135,352 - $201,656
-5,600 Reduced 2.41%
227,100 $6.46 Million
Q1 2021

May 07, 2021

BUY
$32.28 - $44.3 $106,524 - $146,190
3,300 Added 1.44%
232,700 $7.93 Million
Q4 2020

Feb 05, 2021

BUY
$31.45 - $40.54 $12,580 - $16,216
400 Added 0.17%
229,400 $7.64 Million
Q3 2020

Nov 09, 2020

BUY
$26.0 - $34.5 $179,400 - $238,050
6,900 Added 3.11%
229,000 $7.36 Million
Q2 2020

Aug 05, 2020

BUY
$14.11 - $29.42 $811,325 - $1.69 Million
57,500 Added 34.93%
222,100 $6.12 Million
Q1 2020

May 08, 2020

BUY
$13.63 - $33.98 $32,712 - $81,551
2,400 Added 1.48%
164,600 $2.64 Million
Q4 2019

Feb 06, 2020

BUY
$16.12 - $24.98 $106,392 - $164,868
6,600 Added 4.24%
162,200 $3.87 Million
Q3 2019

Nov 12, 2019

BUY
$15.49 - $25.78 $23,235 - $38,670
1,500 Added 0.97%
155,600 $2.75 Million
Q2 2019

Aug 02, 2019

BUY
$23.0 - $32.19 $312,800 - $437,783
13,600 Added 9.68%
154,100 $3.95 Million
Q1 2019

May 10, 2019

BUY
$13.91 - $31.15 $59,813 - $133,945
4,300 Added 3.16%
140,500 $4.08 Million
Q4 2018

Feb 13, 2019

BUY
$11.6 - $18.7 $32,480 - $52,360
2,800 Added 2.1%
136,200 $1.79 Million
Q2 2018

Aug 09, 2018

BUY
$20.0 - $29.72 $130,000 - $193,180
6,500 Added 5.12%
133,400 $3.16 Million
Q1 2018

May 04, 2018

BUY
$21.69 - $32.99 $158,337 - $240,827
7,300 Added 6.1%
126,900 $2.86 Million
Q4 2017

Feb 07, 2018

BUY
$26.43 - $31.78 $74,004 - $88,984
2,800 Added 2.4%
119,600 $3.73 Million
Q3 2017

Nov 03, 2017

BUY
$11.61 - $31.21 $1.36 Million - $3.65 Million
116,800
116,800 $3.65 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.